LISATA THERAPEUTICS, INC. (LSTA) Form 8-K — Aug 4, 2026
$LSTAForm 8-KItems 2.05, 5.02, 8.01, 9.01Filed Aug 4, 2026, 6:01 AM ET0001140361-26-031028Original filing
Lisata Therapeutics announced a 72% reduction in its workforce effective immediately, citing cost-reduction initiatives and the pursuit of strategic options. The Company estimates it will incur approximately $1.2 million in costs related to severance and benefits through the quarter ending September 30, 2026. Dr. Kristen K.
Key figures
- Retention Bonus Usd
- 200000
- Workforce Reduction Cost Usd
- 1200000
- Workforce Reduction Percent
- 72%
Price after filing
1 day: -1.8%7 days: +6.1%30 days: +37.7%
Close on the filing date to close N calendar days later (from $1.14). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.